{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37816843", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "01"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "10", "Day": "10"}], "ELocationID": ["17078", "10.1038/s41598-023-43787-3"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "13", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Oct", "Day": "10"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Novel intrathoracic irrigation using ultrafine ozone bubbles in a rat empyema model.", "Pagination": {"StartPage": "17078", "MedlinePgn": "17078"}, "Abstract": {"AbstractText": ["Dissolved ozone is generally used for sanitization, but it has not been used for thoracic cavity sanitization because of its short half-life (<\u200920\u00a0min) and possible toxicity. We developed a novel solution containing ultrafine ozone bubbles (ozone-UFB) with a fivefold longer half-life than non-UFB ozone. Using an in vitro model, Staphylococcus aureus colonies were counted after exposure to ozone-UFB or non-UFB ozone at the same ozone concentration (0.4\u00a0mg/L). The colony count was significantly lower in the ozone-UFB group than in the non-UFB ozone group (p\u2009=\u20090.034). The effect of repeated pleural irrigation using ozone-UFB and saline was compared in a rat empyema model of S. aureus infection. The bacterial count in the pleural effusion was decreased by at least fivefold following intrathoracic lavage with ozone-UFB (3\u00a0mg/L). To examine the safety of ozone-UFB for intrathoracic use, ozone-UFB with a higher ozone concentration (10\u00a0mg/L) was injected into the thoracic cavities of normal rats. The treatment did not result in any specific pleural damage or elevated serum interleukin-6 concentrations. The findings highlighted the efficacy and safety of ozone-UFB for intrathoracic sanitization, but further studies are needed to determine the optimal therapeutic ozone concentration with appropriate safety margins."], "CopyrightInformation": "\u00a9 2023. Springer Nature Limited."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara\u2011cho, Sakyo\u2011ku, Kyoto, 606\u20118507, Japan."}], "LastName": "Ikeda", "ForeName": "Masaki", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara\u2011cho, Sakyo\u2011ku, Kyoto, 606\u20118507, Japan."}], "LastName": "Yutaka", "ForeName": "Yojiro", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Graduate School of Medicine, Nagoya University, Nagoya, Japan."}], "LastName": "Chen-Yoshikawa", "ForeName": "Toyofumi F", "Initials": "TF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}], "LastName": "Tanaka", "ForeName": "Michio", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}], "LastName": "Yamamoto", "ForeName": "Masaki", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara\u2011cho, Sakyo\u2011ku, Kyoto, 606\u20118507, Japan."}], "LastName": "Tanaka", "ForeName": "Satona", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara\u2011cho, Sakyo\u2011ku, Kyoto, 606\u20118507, Japan."}], "LastName": "Yamada", "ForeName": "Yoshito", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara\u2011cho, Sakyo\u2011ku, Kyoto, 606\u20118507, Japan."}], "LastName": "Ohsumi", "ForeName": "Akihiro", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara\u2011cho, Sakyo\u2011ku, Kyoto, 606\u20118507, Japan."}], "LastName": "Nakajima", "ForeName": "Daisuke", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara\u2011cho, Sakyo\u2011ku, Kyoto, 606\u20118507, Japan."}], "LastName": "Hamaji", "ForeName": "Masatsugu", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan."}], "LastName": "Yoshizawa", "ForeName": "Akihiko", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Energy Science and Technology, Graduate School of Energy Science, Kyoto University, Kyoto, Japan."}], "LastName": "Kusaka", "ForeName": "Eishi", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}], "LastName": "Nagao", "ForeName": "Miki", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara\u2011cho, Sakyo\u2011ku, Kyoto, 606\u20118507, Japan. hdate@kuhp.kyoto-u.ac.jp."}], "LastName": "Date", "ForeName": "Hiroshi", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Therapeutic Irrigation"}, {"QualifierName": [], "DescriptorName": "Staphylococcus aureus"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Empyema"}, {"QualifierName": [], "DescriptorName": "Pleural Effusion"}], "CoiStatement": "MI, YY, and HD have a financial relationship with Yamato Scientific Co., Ltd., which is the company that developed the system used in this study to produce ultrafine ozone bubbles. The other authors have no conflicts of interest or financial ties to disclose. Technical and financial support for the work described in this manuscript was provided by Yamato Scientific Co., Ltd."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Shen KR, Bribriesco A, Crabtree T, Denlinger C, Eby J, Eiken P, et al. The American association for thoracic surgery consensus guidelines for the management of empyema. J. Thorac. Cardiovasc. Surg. 2017;153(6):e129\u2013146. doi: 10.1016/j.jtcvs.2017.01.030.", "ArticleIdList": ["10.1016/j.jtcvs.2017.01.030", "28274565"]}, {"Citation": "Aoki N, Arakawa S, Ouchi K, Ohnishi K, Kaneko A, Kiyota H, et al. The JAID/JSC Guide to Clinical Management of Infectious Diseases. 2019 JAID/JSC Infection Treatment Guide/Guideline Creation Committee. Life Science Publishing Corporation; 2019."}, {"Citation": "Gharagozloo F, Trachiotis G, Wolfe A, DuBree KJ, Cox JL. Pleural space irrigation and modified Clagett procedure for the treatment of early postpneumonectomy empyema. J. Thorac. Cardiovasc. Surg. 1998;116(6):943\u2013948. doi: 10.1016/S0022-5223(98)70044-3.", "ArticleIdList": ["10.1016/S0022-5223(98)70044-3", "9832684"]}, {"Citation": "Hassan M, El-Shaarawy B, Elshazly A, Gadallah M, Sadaka A. Antiseptic pleural irrigation for adult pleural infection. Eur. Respir. J. 2022;60:330. doi: 10.1183/13993003.congress-2022.330.", "ArticleIdList": ["10.1183/13993003.congress-2022.330"]}, {"Citation": "Chaari Z, Hentati A, Ben Ayed A, Abid W, Frikha I. Effectiveness and safety of povidone iodine for prolonged lung air-leak after lung surgery. Asian Cardiovasc. Thorac. Ann. 2022;30(3):314\u2013320. doi: 10.1177/02184923211067637.", "ArticleIdList": ["10.1177/02184923211067637", "34904450"]}, {"Citation": "Muthu V, Dhooria S, Sehgal IS, Prasad KT, Aggarwal AN, Agarwal R. Iodopovidone pleurodesis for malignant pleural effusions: An updated systematic review and meta-analysis. Support Care Cancer. 2021;29(8):4733\u20134742. doi: 10.1007/s00520-021-06004-3.", "ArticleIdList": ["10.1007/s00520-021-06004-3", "33515303"]}, {"Citation": "Nahlovsky J, Matejek T. Chemical pleurodesis with povidone-iodine in congenital chylothorax. Indian J. Pediatr. 2023;90(6):634. doi: 10.1007/s12098-023-04526-8.", "ArticleIdList": ["10.1007/s12098-023-04526-8", "36882662"]}, {"Citation": "Package insert for 10% povidone-iodine solution (Meiji Seika Pharma Co., Ltd., 2023). https://s3-ap-northeast-1.amazonaws.com/medleymedicine/prescriptionpdf/780009_2612701Q3466_2_01.pdf. (Japanese Article)."}, {"Citation": "Package insert for 0.5% chlorhexidine-gluconate solution (Hexizac Water W, Yoshida Pharmaceutical Company, 2023). https://s3-ap-northeast-1.amazonaws.com/medley-medicine/prescriptionpdf/830039_2619702Q1175_1_11.pdf. (Japanese Article)."}, {"Citation": "Broadwater WT, Hoehn RC, King PH. Sensitivity of three selected bacterial species to ozone. Appl. Microbiol. 1973;26(3):391\u2013393. doi: 10.1128/am.26.3.391-393.1973.", "ArticleIdList": ["10.1128/am.26.3.391-393.1973", "PMC379797", "4201643"]}, {"Citation": "Arita M, Nagayoshi M, Fukuizumi T, Okinaga T, Masumi S, Morikawa M, et al. Microbicidal efficacy of ozonated water against Candida albicans adhering to acrylic denture plates. Oral Microbiol. Immunol. 2005;20:206\u2013210. doi: 10.1111/j.1399-302X.2005.00213.x.", "ArticleIdList": ["10.1111/j.1399-302X.2005.00213.x", "15943763"]}, {"Citation": "Botondi R, Barone M, Grasso C. A review into the effectiveness of ozone technology for improving the safety and preserving the quality of fresh-cut fruits and vegetables. Foods. 2021;10:748. doi: 10.3390/foods10040748.", "ArticleIdList": ["10.3390/foods10040748", "PMC8065486", "33915979"]}, {"Citation": "Seki M, Ishikawa T, Terada H, Nashimoto M. Microbicidal effects of stored aqueous ozone solution generated by nano-bubble technology. In Vivo. 2017;31:579\u2013583. doi: 10.21873/invivo.11097.", "ArticleIdList": ["10.21873/invivo.11097", "PMC5566906", "28652423"]}, {"Citation": "Li B, Liu C, Li Y, Yang HF, Du Y, Zhang C, et al. Computed tomography-guided catheter drainage with urokinase and ozone in management of empyema. World J. Radiol. 2017;9(4):212\u2013216. doi: 10.4329/wjr.v9.i4.212.", "ArticleIdList": ["10.4329/wjr.v9.i4.212", "PMC5415891", "28529685"]}, {"Citation": "Hayakumo S, Arakawa S, Mano Y, Izumi Y. Clinical and microbiological effects of ozone nano-bubble water irrigation as an adjunct to mechanical subgingival debridement in periodontitis patients in a randomized controlled trial. Clin. Oral Invest. 2013;17:379\u2013388. doi: 10.1007/s00784-012-0711-7.", "ArticleIdList": ["10.1007/s00784-012-0711-7", "22422082"]}, {"Citation": "Hayakumo S, Arakawa S, Takahashi M, Kondo K, Mano Y, Izumi Y. Effects of ozone nano-bubble water on periodontopathic bacteria and oral cells -in vitro studies. Sci. Technol. Adv. Mater. 2014;15:055003. doi: 10.1088/1468-6996/15/5/055003.", "ArticleIdList": ["10.1088/1468-6996/15/5/055003", "PMC5099676", "27877715"]}, {"Citation": "Iliopoulou M, Skouras V, Psaroudaki Z, Makarona M, Vogiatzakis E, Tsorlini E, et al. Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection. J. Thorac. Dis. 2021;13(2):521\u2013532. doi: 10.21037/jtd-20-2786.", "ArticleIdList": ["10.21037/jtd-20-2786", "PMC7947506", "33717525"]}, {"Citation": "Bocci V. OZONE: A New Medical Drug. 2. Springer; 2011."}, {"Citation": "Azuma T, Usui M, Hayashi T. Inactivation of antibiotic-resistant bacteria in wastewater by ozone-based advanced water treatment processes. Antibiotics. 2022;11(2):210. doi: 10.3390/antibiotics11020210.", "ArticleIdList": ["10.3390/antibiotics11020210", "PMC8868322", "35203813"]}, {"Citation": "Franke G, Knobling B, Brill FH, Becker B, Klupp EM, Campos CB, et al. An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2. J. Hosp. Infect. 2021;112:108\u2013113. doi: 10.1016/j.jhin.2021.04.007.", "ArticleIdList": ["10.1016/j.jhin.2021.04.007", "PMC8046700", "33864891"]}, {"Citation": "Shichiri-Negoro Y, Tsutsumi-Arai C, Arai Y, Satomura K, Arakawa S, Wakabayashi N. Ozone ultrafine bubble water inhibits the early formation of Candida albicans biofilms. PLoS ONE. 2021;16(12):e0261180. doi: 10.1371/journal.pone.0261180.", "ArticleIdList": ["10.1371/journal.pone.0261180", "PMC8664219", "34890423"]}, {"Citation": "Silva EJNL, Prado MC, Soares DN, Hecksher F, Martins JNR, Fidalgo TKS. The effect of ozone therapy in root canal disinfection: A systematic review. Int. Endod. J. 2020;53:317\u2013332. doi: 10.1111/iej.13229.", "ArticleIdList": ["10.1111/iej.13229", "31587303"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "4"}, {"Year": "2023", "Month": "9", "Day": "28"}, {"Year": "2023", "Month": "11", "Day": "1", "Hour": "12", "Minute": "44"}, {"Year": "2023", "Month": "10", "Day": "11", "Hour": "0", "Minute": "42"}, {"Year": "2023", "Month": "10", "Day": "10", "Hour": "23", "Minute": "32"}, {"Year": "2023", "Month": "10", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["37816843", "PMC10564710", "10.1038/s41598-023-43787-3", "10.1038/s41598-023-43787-3"]}}], "PubmedBookArticle": []}